• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Background Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias
detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and …

1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

The application of artificial intelligence (AI) to the electrocardiogram (ECG), a ubiquitous and
standardized test, is an example of the ongoing transformative effect of AI on cardiovascular …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Background Atrial fibrillation is frequently asymptomatic and thus underdetected but is
associated with stroke, heart failure, and death. Existing screening methods require …

Background Cryptogenic strokes constitute 20 to 30% of ischemic strokes, and most
cryptogenic strokes are considered to be embolic and of undetermined source. An earlier …